Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Growth 2024-2030

Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Growth 2024-2030

Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.

The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Extracorporeal Membrane Oxygenation Therapy (ECMO) Industry Forecast” looks at past sales and reviews total world Extracorporeal Membrane Oxygenation Therapy (ECMO) sales in 2023, providing a comprehensive analysis by region and market sector of projected Extracorporeal Membrane Oxygenation Therapy (ECMO) sales for 2024 through 2030. With Extracorporeal Membrane Oxygenation Therapy (ECMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracorporeal Membrane Oxygenation Therapy (ECMO) industry.

This Insight Report provides a comprehensive analysis of the global Extracorporeal Membrane Oxygenation Therapy (ECMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Extracorporeal Membrane Oxygenation Therapy (ECMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Extracorporeal Membrane Oxygenation Therapy (ECMO) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracorporeal Membrane Oxygenation Therapy (ECMO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracorporeal Membrane Oxygenation Therapy (ECMO).

United States market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Extracorporeal Membrane Oxygenation Therapy (ECMO) players cover GETINGE, Terumo, NIPRO, Medtronic, LivaNova, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Extracorporeal Membrane Oxygenation Therapy (ECMO) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Veinous (VA)
Venous (VV)
Arteriovenous (AV)

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GETINGE
Terumo
NIPRO
Medtronic
LivaNova
XENIOS AG
ALung Technologies
EUROSETS
OriGen Biomedical
MicroPort Scientific

Key Questions Addressed in this Report

What is the 10-year outlook for the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market?

What factors are driving Extracorporeal Membrane Oxygenation Therapy (ECMO) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Extracorporeal Membrane Oxygenation Therapy (ECMO) market opportunities vary by end market size?

How does Extracorporeal Membrane Oxygenation Therapy (ECMO) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.